Filters: Format: "application/pdf"
301 - 325 of 443
Number of results to display per page
TitleDateTypeSetname
301 Severe Heavy Eye Syndrome With Esotropia and Hypertropia in a Female With Congenital Monocular Anophthalmia2022-02Textehsl_novel_nam
302 Tendon-sparing Extraocular Muscle Enlargement and Cranial Nerve Hypertrophy in Chronic Inflammatory Demyelinating Polyneuropathy2022-02Textehsl_novel_nam
303 THRIVE: A Phase 3 Trial of VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED)2023-03-14Textehsl_novel_nam
304 Ultramicroscopic study of the Optic Nerve Sheath in Patients with Severe Vision Loss from Idiopathic Intracranial2015-02-22Textehsl_novel_nam
305 Ultramicroscopic study of the Optic Nerve Sheath in Patients with Severe Vision Loss from Idiopathic Intracranial Hypertension - Results2015-02-24Textehsl_novel_nam
306 Ultramicroscopic study of the Optic Nerve Sheath in Patients with Severe Vision Loss from Idiopathic Intracranial Hypertension- Results2015-02-22Textehsl_novel_nam
307 Ultramicroscopic study of the Optic Nerve Sheath in Patients with Severe Vision Loss from Idiopathic Intracranial Hypertension-Methodology2015-02-24Textehsl_novel_nam
308 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients2023-03Textehsl_novel_nam
309 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients2023-03Textehsl_novel_nam
310 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor in Development for Thyroid Eye Disease (TED), Binds to a Distinct Epitope from Teprotumumab2023-03-14Textehsl_novel_nam
311 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor in Development for Thyroid Eye Disease (TED): Interim Phase 1/2 Pharmacodynamic Results2023-03-14Textehsl_novel_nam
312 VRDN-002, a Next-Generation Novel Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Results of a Phase 1 Trial2023-03-14Textehsl_novel_nam
313 A Case of MOG Negative Chronic Relapsing Inflammatory Optic Neuropathy (CRION)2023-03-14Textehsl_novel_nam
314 A Case of Multiple Myeloma Relapse Presenting with Proptosis2020-03Textehsl_novel_nam
315 A Case of Thyroid Eye Disease-associated Ischemic Optic Neuropathy2023-03-14Textehsl_novel_nam
316 Embryonal Rhabdomyosarcoma (Kennerdell Case 41, PPT)Textehsl_novel_jsk
317 Horner Syndrome and Internuclear Ophthalmoplegia From Biopsy Proven Giant Cell Arteritis2022-02Textehsl_novel_nam
318 Multiple Myeloma: Epibulbar Plasmacytoma Causing Diplopia2023-03-14Textehsl_novel_nam
319 Oculomotor Nerve Palsy Associated With Extramedullary Multiple Myeloma2021-02Textehsl_novel_nam
320 Orbital Plasmacytoma as the Initial Manifestation of Multiple Myeloma2023-03-14Textehsl_novel_nam
321 Severe Dysthyroid Orbitopathy (Kennerdell Case 48, PPT)Textehsl_novel_jsk
322 Severe Orbital Lymphangioma (Kennerdell Case 1, PPT)Textehsl_novel_jsk
323 Spin-orbit state-selected reactions of Kr+(2P3/2 and 2P1/2) with H2, D2, and HD from thermal energies to 20 eV c.m.1986Textir_uspace
324 Spontaneous Superior Ophthalmic Vein Thrombosis2019-03Textehsl_novel_nam
325 Walsh & Hoyt: Congenital Anomalies of the Optic Disc2005Textehsl_novel_whts
301 - 325 of 443